Orgenesis Inc. (OTCMKTS:ORGS – Get Free Report)’s share price crossed below its two hundred day moving average during trading on Friday. The stock has a two hundred day moving average of $0.36 and traded as low as $0.35. Orgenesis shares last traded at $0.35, with a volume of 100 shares trading hands.
Orgenesis Stock Performance
The business has a 50 day moving average of $0.31 and a two-hundred day moving average of $0.36. The firm has a market capitalization of $1.81 million, a price-to-earnings ratio of -0.03 and a beta of 3.63.
About Orgenesis
Orgenesis Inc is a biotechnology company focused on cell and gene therapy development and the technologies needed to manufacture these treatments closer to the point of patient care. Its work combines therapeutic programs with bioprocessing systems intended to support the production of personalized, autologous cell therapies.
The company’s technology platform includes its Point-of-Care (POCare) ecosystem and Mobile Processing Units (MPUs). These systems are designed to provide controlled, modular environments for processing patient-derived cells at hospitals, clinics, and other treatment sites, with the goal of reducing reliance on centralized manufacturing facilities.
Orgenesis has pursued collaborations with academic institutions, healthcare organizations, and biotechnology partners in the United States and internationally.
Featured Articles
- Five stocks we like better than Orgenesis
- The Ugly Truth Behind SoundHound’s Q3 Results
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
Receive News & Ratings for Orgenesis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orgenesis and related companies with MarketBeat.com's FREE daily email newsletter.
